发明公开
- 专利标题： INTERFERON-EPSILON
- 专利标题（中）： INTERFERON EPSILON
-
申请号： EP99969444.1申请日： 1999-09-16
-
公开(公告)号： EP1141296A2公开(公告)日： 2001-10-10
- 发明人: CONKLIN, Darrell, C. , GRANT, Francis, J. , RIXON, Mark , KINDSVOGEL, Wayne
- 申请人： ZymoGenetics, Inc.
- 申请人地址： 1201 Eastlake Avenue East Seattle, WA 98102 US
- 专利权人： ZymoGenetics, Inc.
- 当前专利权人： ZymoGenetics, Inc.
- 当前专利权人地址： 1201 Eastlake Avenue East Seattle, WA 98102 US
- 代理机构： Schlich, George William
- 优先权： US157068 19980918; US245293 19990205; US350232 19990708
- 国际公布： WO0017361 20000330
- 主分类号： C12N15/20
- IPC分类号： C12N15/20 ; C07K14/555 ; C12N15/62 ; C07K16/24 ; A61K38/21 ; C12Q1/68 ; C12N7/01 ; A61K31/70 ; C12N5/10 ; A61K48/00
摘要：
Interferons represent an important class of biopharmaceutical products, which have a proven track record in the treatment of a variety of medical conditions, including the treatment of certain autoimmune diseases, the treatment of particular cancers, and the enhancement of the immune response against infectious agents. To date, four types of interferons have been found in humans: interferon-α, interferon-β, interferon-η, and interferon-φ. The present invention provides new forms of human and murine interferon, 'interferon-ε', which have applications in diagnosis and therapy.
信息查询
IPC分类:
